[go: up one dir, main page]

CN108102915A - A kind of mediate contact co-culture system for being engineered amplification - Google Patents

A kind of mediate contact co-culture system for being engineered amplification Download PDF

Info

Publication number
CN108102915A
CN108102915A CN201810014471.6A CN201810014471A CN108102915A CN 108102915 A CN108102915 A CN 108102915A CN 201810014471 A CN201810014471 A CN 201810014471A CN 108102915 A CN108102915 A CN 108102915A
Authority
CN
China
Prior art keywords
cells
solution
indirect contact
hydrogel
alginate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810014471.6A
Other languages
Chinese (zh)
Inventor
于炜婷
刘袖洞
梁珊珊
王若雨
马小军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian University
Original Assignee
Dalian University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian University filed Critical Dalian University
Priority to CN201810014471.6A priority Critical patent/CN108102915A/en
Publication of CN108102915A publication Critical patent/CN108102915A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/16Particles; Beads; Granular material; Encapsulation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/16Particles; Beads; Granular material; Encapsulation
    • C12M25/18Fixed or packed bed
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/16Particles; Beads; Granular material; Encapsulation
    • C12M25/20Fluidized bed
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068General culture methods using substrates
    • C12N5/0075General culture methods using substrates using microcarriers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/50Proteins
    • C12N2533/52Fibronectin; Laminin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/50Proteins
    • C12N2533/54Collagen; Gelatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/70Polysaccharides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/70Polysaccharides
    • C12N2533/72Chitin, chitosan
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/70Polysaccharides
    • C12N2533/74Alginate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Sustainable Development (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

本发明公开了一种可工程化、规模化放大的间接接触共培养体系及其制备方法。该体系由承装有众多微小单元颗粒的生物反应器构成。其微小单元颗粒为粒径在100‑1000微米的球形水凝胶载体,该水凝胶球表面具有一层水凝胶膜结构。一种细胞在球形水凝胶内部,另一种细胞分布在球形水凝胶膜表面,形成两种细胞可以通过水凝胶膜的膜孔发生细胞膜的接触,又方便下游分离的细胞间接接触共培养单元。

The invention discloses an engineerable and scalable indirect contact co-cultivation system and a preparation method thereof. The system is composed of a bioreactor containing many tiny unit particles. The tiny unit particles are spherical hydrogel carriers with a particle size of 100-1000 microns, and the surface of the hydrogel ball has a layer of hydrogel film structure. One type of cells is inside the spherical hydrogel, and the other type of cells is distributed on the surface of the spherical hydrogel membrane, forming two types of cells that can contact the cell membrane through the membrane pores of the hydrogel membrane, and facilitate the indirect contact of downstream separated cells. culture unit.

Description

一种可工程化放大的间接接触共培养体系An indirect contact co-culture system that can be engineered and scaled up

技术领域technical field

本发明涉及一种间接接触共培养体系,特别是一种球形膜为特征的间接接触共培养体系。The invention relates to an indirect contact co-cultivation system, in particular to an indirect contact co-cultivation system characterized by a spherical membrane.

背景技术Background technique

细胞共培养技术为细胞生物学的体外研究提供了可能。而目前的共培养技术按照共培养细胞间的接触程度分为直接接触共培养、非接触共培养和间接接触共培养三种。其中,直接接触共培养技术由于共培养的细胞间发生充分接触,利于细胞功能的发挥,但缺点是共培养结束后,两种细胞很难分离,只能通过将其中一种细胞进行荧光标记后通过流式分选分离,或者将其中一种细胞进行免疫磁珠标记后通过磁场分离获得,这种分离方法非常繁琐而且价格昂贵。相比之下,非接触共培养技术比较容易实现两种细胞的分离,但缺点是由于两种细胞间没有发生接触,导致基质细胞对实质细胞并未显示出显著的支持功能,因此,能够兼顾直接接触与非接触优势的间接接触共培养技术显示了优势,其既利于基质细胞支持功能的发挥又利于共培养细胞的分离。目前,已经公开的细胞间接接触共培养技术包括两种:一种是通过transwell平板膜,将两种细胞分别接种到膜的上下表面构建成间接接触共培养体系,通过调控膜的孔隙率来调控细胞间的接触程度。另一种是通过微加工技术加工成可相互对插的一对梳状结构,将细胞共培养的两种细胞分别接种到每个梳状结构表面,构建成间接接触共培养体系,通过这对梳状结构对插深度调控细胞间的接触程度,培养后的细胞通过将对插梳状结构的分离而分离。这两种培养方式的最大问题在于其间接接触共培养体系仅能用于实验室研究,难以实现工程化放大,无法满足细胞产品的生产需求。Cell co-culture technology provides the possibility for the in vitro study of cell biology. According to the degree of contact between co-cultured cells, the current co-culture technology is divided into three types: direct contact co-culture, non-contact co-culture and indirect contact co-culture. Among them, the direct contact co-culture technology is beneficial to the function of the cells due to the full contact between the co-cultured cells, but the disadvantage is that after the co-cultivation is over, it is difficult to separate the two cells, and only one of the cells can be fluorescently labeled. Separation by flow sorting, or by magnetic field separation after one of the cells has been labeled with immunomagnetic beads, is tedious and expensive. In contrast, the non-contact co-culture technique is relatively easy to separate the two types of cells, but the disadvantage is that the stromal cells do not show significant support functions for the parenchymal cells due to the absence of contact between the two types of cells. The direct contact and non-contact advantages of the indirect contact co-culture technology show advantages, which are conducive to both the support function of stromal cells and the separation of co-cultured cells. At present, there are two types of cell indirect contact co-culture technologies that have been disclosed: one is to inoculate two kinds of cells on the upper and lower surfaces of the membrane through the transwell flat membrane to construct an indirect contact co-culture system, which is regulated by regulating the porosity of the membrane. The degree of contact between cells. The other is to process a pair of comb-like structures that can be inserted into each other through micro-processing technology, and inoculate two types of cells co-cultured on the surface of each comb-like structure to construct an indirect contact co-culture system. The depth of the comb-like structure regulates the degree of contact between cells, and the cultured cells are separated by separating the pair of comb-like structures. The biggest problem with these two culture methods is that their indirect contact co-culture system can only be used for laboratory research, it is difficult to achieve engineering scale-up, and cannot meet the production needs of cell products.

发明内容Contents of the invention

本发明为解决上述技术问题所采用的技术方案为:提供一种可工程化放大的间接接触共培养体系,该体系由承装有众多微小单元颗粒的生物反应器构成,其微小单元颗粒为粒径在100-1000微米的球形水凝胶载体,该水凝胶载体为壳核结构,表面具有一层水凝胶膜,一种细胞在球形水凝胶内部,另一种细胞分布在球形水凝胶膜表面,形成两种细胞间可以通过水凝胶膜的孔隙发生细胞接触,又方便两种细胞下游分离的细胞间接接触共培养单元。The technical scheme adopted by the present invention to solve the above-mentioned technical problems is: to provide an indirect contact co-cultivation system that can be engineered and scaled up. A spherical hydrogel carrier with a diameter of 100-1000 microns, the hydrogel carrier is a shell-core structure with a layer of hydrogel film on the surface, one type of cells is inside the spherical hydrogel, and the other type of cells is distributed in the spherical water On the surface of the gel membrane, cell contact between the two types of cells can occur through the pores of the hydrogel membrane, and it is convenient for the cells separated downstream of the two types of cells to indirectly contact the co-culture unit.

进一步的,所述的生物反应器为流化床生物反应器、固定床生物反应器、搅拌式生物反应器或旋转生物反应器。Further, the bioreactor is a fluidized bed bioreactor, a fixed bed bioreactor, a stirred bioreactor or a rotary bioreactor.

进一步的,所述的分布在生物反应器中的微小单元颗粒总体积占据生物反应器容积的10-90%。Further, the total volume of the tiny unit particles distributed in the bioreactor occupies 10-90% of the volume of the bioreactor.

进一步的,所述的球形水凝胶载体的成分包括海藻酸盐、壳聚糖;同时还含有胶原、基质胶、硫酸软骨素、纤连蛋白中的一种或一种以上。Further, the spherical hydrogel carrier includes alginate, chitosan, and one or more of collagen, matrigel, chondroitin sulfate, and fibronectin.

进一步的,所述的球形水凝胶载体的壳部分是壳聚糖与海藻酸盐混合物之间通过静电交联形成的聚电解质络合水凝胶膜,膜厚在30微米以下,膜孔隙在5微米以下。Further, the shell part of the spherical hydrogel carrier is a polyelectrolyte complexed hydrogel film formed by electrostatic crosslinking between chitosan and alginate mixture, the film thickness is below 30 microns, and the film pores are Below 5 microns.

进一步的,在所述球形水凝胶载体中,海藻酸盐包括海藻酸钙盐或海藻酸钡盐中的一种或二种。Further, in the spherical hydrogel carrier, the alginate includes one or both of calcium alginate or barium alginate.

制备微小单元颗粒的方法为:The method for preparing tiny unit particles is as follows:

A、配制浓度10-50g/L的海藻酸盐溶液(海藻酸钠或海藻酸钾中的一种或两种);A, prepare the alginate solution (one or both in sodium alginate or potassium alginate) of concentration 10-50g/L;

B、配制浓度2-50g/L的胶原溶液、壳聚糖溶液、基质胶溶液、硫酸软骨素溶液或纤连蛋白溶液;B. Collagen solution, chitosan solution, matrigel solution, chondroitin sulfate solution or fibronectin solution with a concentration of 2-50g/L are prepared;

C、配制凝胶浴水溶液:凝胶浴中含有总浓度5-30g/L氯化钙或氯化钡的一种或两种;还含有总浓度1-20g/L氯化钠或氯化钾中的一种或二种;还含有总浓度0.5-20g/L柠檬酸钠或磷酸钠或磷酸氢二钠或磷酸二氢钠中的一种或二种以上;还含有总浓度0-30g/L吐温或F68中的一种或二种;C. Preparation of gel bath aqueous solution: the gel bath contains one or two kinds of calcium chloride or barium chloride with a total concentration of 5-30g/L; it also contains sodium chloride or potassium chloride with a total concentration of 1-20g/L One or two of them; it also contains one or more of the total concentration of 0.5-20g/L sodium citrate or sodium phosphate or disodium hydrogen phosphate or sodium dihydrogen phosphate; it also contains a total concentration of 0-30g/L One or two of L Tween or F68;

D、配制浓度1-10g/L壳聚糖溶液;D, preparation concentration 1-10g/L chitosan solution;

E、将步骤A配制的海藻酸钠溶液与步骤B配制的胶原溶液、壳聚糖溶液、基质胶溶液、硫酸软骨素溶液或纤连蛋白溶液中的一种或一种以上均匀混合,混合液中海藻酸钠浓度保持在10g/L以上;E, uniformly mix the sodium alginate solution prepared in step A with one or more of the collagen solution prepared in step B, chitosan solution, matrigel solution, chondroitin sulfate solution or fibronectin solution, the mixed solution The concentration of sodium alginate in the medium is kept above 10g/L;

F、将收集的细胞a均匀分散到步骤E制备的混合液中,将含有细胞a的混合溶液通过流体颗粒化技术,形成均匀液滴,液滴进入步骤C配制的凝胶浴溶液中,同时结合温度变化(如果含有胶原成分,升高温度到37℃以上),发生凝胶化反应,即得包埋有细胞a的球形水凝胶载体内核部分;F. Evenly disperse the collected cell a into the mixed solution prepared in step E, pass the mixed solution containing cell a through fluid granulation technology to form uniform droplets, and the droplets enter the gel bath solution prepared in step C, and at the same time Combining with temperature changes (if it contains collagen components, increase the temperature to above 37°C), a gelation reaction occurs, that is, the core part of the spherical hydrogel carrier embedded with cells a is obtained;

G、将步骤F获得的包埋有细胞a的球形水凝胶载体内核部分与步骤D配制的壳聚糖溶液反应成膜,载体与壳聚糖溶液的体积比为1:2-1:10,让载体在壳聚糖溶液中处于均匀悬浮状态,进行聚电解质络合反应2-60分钟,即在球形水凝胶载体内核表面形成水凝胶膜,生理盐水或PBS溶液清洗后获得壳核结构的细胞a分布在内部的水凝胶载体;G. React the core part of the spherical hydrogel carrier embedded with cell a obtained in step F with the chitosan solution prepared in step D to form a film, and the volume ratio of the carrier to the chitosan solution is 1:2-1:10 , let the carrier be in a uniform suspension state in the chitosan solution, and carry out the polyelectrolyte complexation reaction for 2-60 minutes, that is, a hydrogel film is formed on the surface of the spherical hydrogel carrier inner core, and the shell core is obtained after washing with normal saline or PBS solution Structured cells a distributed inside the hydrogel carrier;

H、将细胞b与步骤G制备的包埋有细胞a的水凝胶载体共孵育1-24小时,获得一种细胞在球形水凝胶内部,另一种细胞分布在球形水凝胶膜表面的间接接触共培养微小单元颗粒。H. Co-incubate cell b with the hydrogel carrier embedded with cell a prepared in step G for 1-24 hours to obtain one type of cell inside the spherical hydrogel and another type of cell distributed on the surface of the spherical hydrogel membrane Indirect contact co-cultivation of tiny unit particles.

进一步的,在所述的球形水凝胶载体制备工艺中,流体颗粒化技术为高压静电场技术、气体锐孔喷雾技术、微流控技术或乳化技术,所制备的球形水凝胶载体的粒径单分散。Further, in the preparation process of the spherical hydrogel carrier, the fluid granulation technology is high-voltage electrostatic field technology, gas orifice spray technology, microfluidic technology or emulsification technology, and the prepared spherical hydrogel carrier particles monodisperse.

所述的一种可工程化放大的间接接触共培养体系,可用于肝细胞与基质细胞体外间接接触共培养;干细胞与诱导细胞体外间接接触共培养;干细胞与滋养层细胞体外间接接触共培养;肿瘤细胞与基质细胞体外间接接触共培养等各种需要两种细胞共培养的体系,且共培养结束后,胰酶即可将分布在微小单元颗粒表面的细胞消化下来,实现共培养细胞的分离。The indirect contact co-cultivation system that can be engineered and enlarged can be used for in vitro indirect contact co-cultivation of hepatocytes and stromal cells; in vitro indirect contact co-cultivation of stem cells and induced cells; in vitro indirect contact co-cultivation of stem cells and trophoblast cells; Indirect contact co-culture of tumor cells and stromal cells in vitro and other systems that require co-cultivation of two kinds of cells, and after co-cultivation, trypsin can digest the cells distributed on the surface of micro-unit particles to realize the separation of co-cultured cells .

本发明的有益效果:Beneficial effects of the present invention:

1.该间接接触共培养体系,通过球形膜的构建,大大增加了单位体积载体的膜面积,且球体粒径在100-1000微米,比已公开的平板膜(transwell膜)技术更利于工程化放大;1. The indirect contact co-culture system, through the construction of a spherical membrane, greatly increases the membrane area per unit volume of the carrier, and the spherical particle size is 100-1000 microns, which is more conducive to engineering than the disclosed flat membrane (transwell membrane) technology enlarge;

2.细胞a在球形水凝胶内部呈三维状态生长,更模拟体内微环境,利于细胞生理功能发挥;2. Cell a grows in a three-dimensional state inside the spherical hydrogel, which more simulates the microenvironment in vivo and is conducive to the physiological function of cells;

3.以球形水凝胶微球构成的微小单元颗粒,可在各种生物反应器中培养,实现规模化放大;3. Micro unit particles composed of spherical hydrogel microspheres can be cultivated in various bioreactors to achieve scale-up;

4.共培养结束后,通过胰酶即可将分布在球形水凝胶载体表面的细胞b消化下来,实现细胞a与细胞b的分离,分别进行研究或作为细胞产品。4. After the co-cultivation, the cells b distributed on the surface of the spherical hydrogel carrier can be digested by trypsin, so as to realize the separation of cells a and b, which can be studied separately or used as cell products.

附图说明Description of drawings

图1为间接接触共培养体系中微小单元颗粒的制备方法示意图。Fig. 1 is a schematic diagram of the preparation method of tiny unit particles in an indirect contact co-culture system.

图2为实施例1中实验组与两组对照组的实验设计示意图:示意图为在载有微小单元颗粒的生物反应器的横截面。FIG. 2 is a schematic diagram of the experimental design of the experimental group and the two control groups in Example 1: the schematic diagram is a cross-section of a bioreactor loaded with tiny unit particles.

其中,图A中的微小单元颗粒为间接接触共培养微小单元颗粒;图B中的微小单元颗粒为对照组1,即单独载有肝细胞的微小单元颗粒;图C为对照组2,即单独载有肝细胞的微小单元颗粒(小粒径)与单独载有血管内皮细胞的微小单元颗粒(大粒径)的非接触共培养体系。Among them, the micro-unit particles in Figure A are indirect contact co-culture micro-unit particles; the micro-unit particles in Figure B are the control group 1, that is, the micro-unit particles loaded with liver cells alone; A non-contact co-culture system of micro-unit particles (small particle size) loaded with hepatocytes and micro-unit particles (large particle size) loaded with vascular endothelial cells alone.

具体实施方式Detailed ways

形成流体颗粒化技术包括:静电液滴法[1]、锐孔挤出法[2]、乳化-外部凝胶化[3]、乳化-内部凝胶化法[4]、膜乳化法[5]、微流控法[6]Fluid granulation techniques include: electrostatic droplet method [1] , orifice extrusion method [2] , emulsification-external gelation method [3] , emulsification-internal gelation method [4] , membrane emulsification method [5] ] , microfluidic method [6] .

实施例1Example 1

【1】配制海藻酸钠溶液,浓度30g/L;【1】Prepare sodium alginate solution with a concentration of 30g/L;

【2】配制胶原溶液,浓度为5g/L,用NaOH调节至中性;[2] Prepare a collagen solution with a concentration of 5g/L and adjust it to neutral with NaOH;

【3】配制凝胶浴溶液,凝胶浴中含有氯化钙(浓度7g/L),氯化钠(浓度3g/L),磷酸二氢钠(浓度1g/L)和F68溶液(1g/L);[3] Prepare the gel bath solution, which contains calcium chloride (concentration 7g/L), sodium chloride (concentration 3g/L), sodium dihydrogen phosphate (concentration 1g/L) and F68 solution (1g/L) in the gel bath. L);

【4】配制壳聚糖溶液,浓度为5g/L;【4】Preparation of chitosan solution, the concentration is 5g/L;

【5】将步骤【1】配制的海藻酸钠溶液与步骤【2】配制的胶原溶液2:1体积比混合;[5] Mix the sodium alginate solution prepared in step [1] with the collagen solution prepared in step [2] in a volume ratio of 2:1;

【6】将培养至对数生长期的肝实质细胞离心收集,按照1×106/ml的密度均匀分散到步骤【5】制备的混合液中;[6] Collect the hepatic parenchymal cells cultured to the logarithmic growth phase by centrifugation, and evenly disperse them into the mixed solution prepared in step [5] at a density of 1×106/ml;

【7】将步骤【6】制备的含有肝实质细胞的海藻酸钠与胶原的混合液,在高压静电场下形成稳定射流,喷入到步骤【3】制备的凝胶浴中,并将凝胶浴植入细胞培养箱中,37℃凝胶化反应30分钟后,即制备得到包埋有肝实质细胞的海藻酸钠-胶原共混水凝胶微球;[7] The mixture of sodium alginate and collagen containing hepatic parenchymal cells prepared in step [6] forms a stable jet under a high-voltage electrostatic field, sprays it into the gel bath prepared in step [3], and The gel bath was implanted into the cell incubator, and after gelation reaction at 37°C for 30 minutes, the sodium alginate-collagen blended hydrogel microspheres embedded with hepatic parenchymal cells were prepared;

【8】将步骤【7】制得的微球与壳聚糖溶液成膜反应10分钟,生理盐水洗涤3遍,即获得包埋有肝实质细胞的壳核结构的海藻酸盐-胶原-壳聚糖微球,微球粒径300±100微米;[8] React the microspheres prepared in step [7] with chitosan solution for 10 minutes, wash with saline 3 times, and obtain the alginate-collagen-shell with a putamen structure embedded with hepatic parenchymal cells Polysaccharide microspheres, the particle size of the microspheres is 300±100 microns;

【9】将培养至对数生长期的血管内皮细胞消化下来,与步骤【8】制得的含有肝实质细胞的壳核结构的海藻酸盐-胶原-壳聚糖微球按照1×105细胞/ml微球的比例,共同培养在预先用琼脂糖处理的培养皿中,于细胞培养箱中共孵育,定期震荡使血管内皮细胞均匀粘附到微球表面。整个制备过程的示意图见附图1。[9] Digest the vascular endothelial cells cultured to the logarithmic growth phase, and mix the alginate-collagen-chitosan microspheres containing the putamen structure of hepatic parenchymal cells prepared in step [8] according to 1×105 cells Ratio of /ml microspheres, co-cultivate in the culture dish pre-treated with agarose, co-incubate in the cell culture box, shake regularly to make the vascular endothelial cells evenly adhere to the surface of the microspheres. The schematic diagram of the whole preparation process is shown in Figure 1.

对照组1为步骤【8】制备出的包埋有肝实质细胞的壳核结构的海藻酸盐-胶原-壳聚糖微球(单独肝细胞培养组);Control group 1 is the alginate-collagen-chitosan microspheres prepared in step [8] embedded with the putamen structure of hepatic parenchymal cells (hepatocyte culture group alone);

对照组2为将血管内皮细胞按照步骤【1】-【8】,制备出粒径在800±100微米的海藻酸盐-胶原-壳聚糖微球中(非接触共培养组)。对照组实验设计示意图见附图2。Control group 2 is to prepare vascular endothelial cells in alginate-collagen-chitosan microspheres with a particle size of 800±100 microns according to steps [1]-[8] (non-contact co-culture group). The schematic diagram of the experimental design of the control group is shown in Figure 2.

【10】将步骤【9】制备的内部载有肝实质细胞、表面粘附血管内皮细胞的海藻酸盐-胶原-壳聚糖水凝胶微球与培养基按照1:5体积比混合后在搅拌式生物反应器中培养。[10] Mix the alginate-collagen-chitosan hydrogel microspheres prepared in step [9] with hepatic parenchymal cells inside and vascular endothelial cells on the surface with the medium at a volume ratio of 1:5 and stir cultured in a bioreactor.

对照组1,将仅包埋肝实质细胞的海藻酸盐-胶原-壳聚糖水凝胶微球与培养基按照1:5体积比混合后在搅拌式生物反应器中培养。In control group 1, the alginate-collagen-chitosan hydrogel microspheres that only embed hepatic parenchymal cells were mixed with the medium at a volume ratio of 1:5 and cultured in a stirred bioreactor.

对照组2,将包埋有血管内皮细胞的800微米粒径微球与步骤【8】制备的包埋有肝实质细胞的300微米粒径微球按照1:10的体积比共混后,微球总体积与培养基按照1:5体积比混合后在搅拌式生物反应器中培养。For control group 2, the 800-micron particle size microspheres embedded with vascular endothelial cells and the 300-micron particle size microspheres embedded with hepatic parenchymal cells prepared in step [8] were blended according to the volume ratio of 1:10, and the microspheres were mixed. The total volume of the spheres was mixed with the medium in a volume ratio of 1:5 and cultured in a stirred bioreactor.

【11】培养结束后,通过自然沉降即可收集水凝胶微球,清洗后胰酶消化粘附到微球表面的血管内皮细胞,留下内部含有培养扩增的肝实质细胞的水凝胶微球,用于体外生物人工肝支持系统的研究。【11】After the culture is over, the hydrogel microspheres can be collected by natural sedimentation. After washing, the vascular endothelial cells adhered to the surface of the microspheres are digested with trypsin, and the hydrogel containing cultured and expanded hepatic parenchymal cells is left Microspheres for the study of in vitro bioartificial liver support systems.

对照组1,直接自然沉降收集包埋有肝实质细胞的水凝胶微球即可。For control group 1, the hydrogel microspheres embedded with hepatic parenchymal cells can be collected directly by natural sedimentation.

对照组2,将自然沉降收集的两个粒径的水凝胶微球,通过孔径600微米筛网进行物理分离,获得300微米粒径的仅包埋有肝实质细胞的水凝胶微球。In control group 2, hydrogel microspheres with two particle sizes collected by natural sedimentation were physically separated through a sieve with a pore size of 600 microns to obtain hydrogel microspheres with a particle size of 300 microns and only embedded hepatic parenchymal cells.

【12】取少量步骤【11】培养后的间接接触共培养微球,参考文献[7][8][9]的方法,检测肝实质细胞功能,结果显示,间接接触共培养获得的肝细胞与单独培养组和非接触共培养组获得的肝细胞相比,白蛋白分泌量、尿素合成能力在间接接触共培养组显著增强;肝细胞代谢相关基因(Cyp 1A2、Cyp 2B1和Cyp 1A2)、载脂蛋白相关基因(ApoA-1)、肝细胞核转录因子(HNF-4α)和白蛋白基因的表达水平在在间接接触共培养组显著增强;睾酮和非那西汀代谢能力在间接接触共培养组显著增强。[12] Take a small amount of indirect contact co-cultured microspheres after step [11], and use the method of reference [7][8][9] to detect the function of hepatic parenchymal cells. The results show that the hepatocytes obtained by indirect contact co-culture Compared with the hepatocytes obtained from the single culture group and the non-contact co-culture group, albumin secretion and urea synthesis ability were significantly enhanced in the indirect contact co-culture group; The expression levels of apolipoprotein-related gene (ApoA-1), hepatocyte nuclear transcription factor (HNF-4α) and albumin gene were significantly enhanced in the indirect contact co-culture group; group was significantly enhanced.

实施例2Example 2

【1】配制海藻酸钠溶液,浓度40g/L;【1】Prepare sodium alginate solution with a concentration of 40g/L;

【2】配制胶原溶液,浓度为4g/L,用NaOH调节至中性;[2] Prepare a collagen solution with a concentration of 4g/L and adjust it to neutral with NaOH;

【3】配制凝胶浴溶液,凝胶浴中含有氯化钙(浓度7g/L),氯化钠(浓度3g/L),磷酸二氢钠(浓度1g/L);[3] Prepare the gel bath solution, which contains calcium chloride (concentration 7g/L), sodium chloride (concentration 3g/L), sodium dihydrogen phosphate (concentration 1g/L) in the gel bath;

【4】配制壳聚糖溶液,浓度为5g/L;【4】Preparation of chitosan solution, the concentration is 5g/L;

【5】将步骤【1】配制的海藻酸钠溶液与步骤【2】配制的胶原溶液1:2体积比混合;[5] Mix the sodium alginate solution prepared in step [1] with the collagen solution prepared in step [2] in a volume ratio of 1:2;

【6】将培养至对数生长期的胎鼠成纤维细胞离心收集,按照2×105/ml的密度均匀分散到步骤【5】制备的混合液中;[6] Centrifuge the fetal rat fibroblasts cultured to the logarithmic growth phase, and uniformly disperse them into the mixture prepared in step [5] at a density of 2×10 5 /ml;

【7】将步骤【6】制备的含有胎鼠成纤维细胞的海藻酸钠与胶原的混合液,与步骤【3】制备的凝胶浴溶液,通过微流控T型通道,制备出粒径在300微米的预凝胶微粒,收集预凝胶微粒于步骤【3】制备的凝胶浴中,放入细胞培养箱中,37℃凝胶化反应30分钟后,即制备得到包埋有胎鼠成纤维细胞的海藻酸钠-胶原共混水凝胶微球;[7] The mixture of sodium alginate and collagen containing fetal mouse fibroblasts prepared in step [6] and the gel bath solution prepared in step [3] were passed through the microfluidic T-shaped channel to prepare the particle size For 300-micron pre-gel particles, collect the pre-gel particles in the gel bath prepared in step [3], put them in the cell culture incubator, and gelatinize at 37°C for 30 minutes to prepare the embryo-embedded cells. Sodium alginate-collagen blended hydrogel microspheres of mouse fibroblasts;

【8】将步骤【7】制得的微球与壳聚糖溶液成膜反应10分钟,生理盐水洗涤3遍,即获得包埋有胎鼠成纤维细胞的壳核结构的海藻酸盐-胶原-壳聚糖微球,微球粒径300±30微米;培养5天后,细胞进入对数生长期末后,收集凝胶微球;[8] The microspheres prepared in step [7] were reacted with chitosan solution for 10 minutes, washed with normal saline for 3 times, and then the alginate-collagen with a putamen structure embedded with fetal mouse fibroblasts was obtained. -Chitosan microspheres, the particle size of the microspheres is 300±30 microns; after 5 days of culture, the cells enter the end of the logarithmic growth phase, and the gel microspheres are collected;

【9】将人胚胎干细胞,与步骤【8】制得的含有胎鼠成纤维细胞的壳核结构的海藻酸盐-胶原-壳聚糖微球按照2×105细胞/ml微球的比例,共同培养在预先用琼脂糖处理的培养容器中,于细胞培养箱中共孵育,定期震荡使干细胞均匀粘附到微球表面;[9] Human embryonic stem cells, and the alginate-collagen-chitosan microspheres containing the putamen structure of fetal mouse fibroblasts prepared in step [8] according to the ratio of 2×10 5 cells/ml microspheres , co-cultivate in the pre-treated culture container with agarose, co-incubate in the cell culture box, shake regularly to make the stem cells evenly adhere to the surface of the microsphere;

【10】将步骤【9】制备的内部载有胎鼠成纤维细胞、表面粘附人胚胎干细胞的海藻酸盐-胶原-壳聚糖水凝胶微球与培养基按照1:5体积比混合后在流化床生物反应器中培养;[10] Mix the alginate-collagen-chitosan hydrogel microspheres prepared in step [9] with fetal mouse fibroblasts inside and human embryonic stem cells adhered to the surface with the medium at a volume ratio of 1:5 Cultivated in a fluidized bed bioreactor;

【11】培养结束后,通过自然沉降即可收集水凝胶微球,清洗后胰酶在微球表面扩增的人胚胎干细胞,检测细胞干性相关基因的表达情况,发现Sox2/Nanog/Oct4与P1代没有差异。[11] After the culture is over, the hydrogel microspheres can be collected by natural sedimentation, and the human embryonic stem cells amplified on the surface of the microspheres by trypsin after washing are detected to detect the expression of stemness-related genes, and it is found that Sox2/Nanog/Oct4 There is no difference from the P1 generation.

参考文献:references:

【1】In Vivo Culture of Encapsulated Endostatin-Secreting ChineseHamster Ovary Cells for Systemic Tumor Inhibition.Human Gene Therapy.2007,18:474-481;【1】In Vivo Culture of Encapsulated Endostatin-Secreting Chinese Hamster Ovary Cells for Systemic Tumor Inhibition.Human Gene Therapy.2007,18:474-481;

【2】一种高经济鱼类微球开口饵料的制备方法,中国发明专利,200510136769.7;[2] A preparation method of high-economic fish microsphere opening bait, Chinese invention patent, 200510136769.7;

【3】Preparation of lactic acid bacteria-enclosing alginate beads inemulsio-n system:effect of preparation parameters on bead characteristics,Polym.Bull,2009,63:599-607;【3】Preparation of lactic acid bacteria-enclosing alginate beads inemulsio-n system: effect of preparation parameters on bead characteristics, Polym.Bull, 2009, 63: 599-607;

【4】乳化-内部凝胶化工艺制备固定化酵母微胶囊,化工学报,2009,60(3):710-717;【4】Preparation of immobilized yeast microcapsules by emulsification-internal gelation process, Chinese Journal of Chemical Industry, 2009, 60(3): 710-717;

【5】Preparation of uniform calcium alginate gel beads by membrane emu-lsification coupled with internal gelation。Journal of Applied PolymerScience,2003,87(5):848-852;【5】Preparation of uniform calcium alginate gel beads by membrane emu-lsification coupled with internal gelation. Journal of Applied Polymer Science, 2003, 87(5): 848-852;

【6】Microfluidic Generation of Monodisperse,Structurally HomogeneousAlginate Microgels for Cell Encapsulation and 3D Cell Culture,Adv.HealthcareMater.2015,4(11):1628-1633;【6】Microfluidic Generation of Monodisperse, Structurally Homogeneous Alginate Microgels for Cell Encapsulation and 3D Cell Culture, Adv.HealthcareMater.2015,4(11):1628-1633;

【7】Fabrication of stable galactosylated alginate microcapsules viacovalent coupling onto hydroxyl groups for hepatocytesapplications.Carbohydrate Polymers,2017,456-465;【7】Fabrication of stable galactosylated alginate microcapsules viacovalent coupling onto hydroxyl groups for hepatocytes applications. Carbohydrate Polymers, 2017, 456-465;

【8】Microfabrication of a tunable collagen/alginate-chitosan hydrogelmembrane for controlling cell-cell interactions.Carbohydrate Polymers,2016,153:652-662;【8】Microfabrication of a tunable collagen/alginate-chitosan hydrogelmembrane for controlling cell-cell interactions.Carbohydrate Polymers,2016,153:652-662;

【9】载细胞海藻酸钠/壳聚糖微胶囊的化学破囊方法研究。高等学校化学学报,2004,25(7):1342-1346。【9】Research on the chemical capsule breaking method of sodium alginate/chitosan microcapsules loaded with cells. Chemical Journal of Chinese Universities, 2004, 25(7): 1342-1346.

Claims (9)

1.一种可工程化放大的间接接触共培养体系,其特征在于,体系由承装有众多微小单元颗粒的生物反应器构成,其微小单元颗粒为粒径在100-1000微米的球形水凝胶载体,该水凝胶载体为壳核结构,表面具有一层水凝胶膜,一种细胞在球形水凝胶内部,另一种细胞分布在球形水凝胶膜表面,形成两种细胞间可以通过水凝胶膜的孔隙发生细胞接触,又方便两种细胞下游分离的细胞间接接触共培养单元。1. An indirect contact co-cultivation system that can be engineered and enlarged is characterized in that the system is composed of a bioreactor equipped with many tiny unit particles, and its tiny unit particles are spherical hydrogels with a particle size of 100-1000 microns Glue carrier, the hydrogel carrier has a shell-core structure with a layer of hydrogel film on the surface, one type of cells is inside the spherical hydrogel, and the other type of cells is distributed on the surface of the spherical hydrogel film, forming a gap between two types of cells. Cell contact can occur through the pores of the hydrogel membrane, and it is convenient for the cells separated downstream of the two cells to indirectly contact the co-culture unit. 2.如权利要求1所述的一种可工程化放大的间接接触共培养体系,其特征在于,所述的生物反应器为流化床生物反应器、固定床生物反应器、搅拌式生物反应器或旋转生物反应器。2. A kind of indirect contact co-cultivation system that can be enlarged by engineering as claimed in claim 1, is characterized in that, described bioreactor is fluidized bed bioreactor, fixed bed bioreactor, stirring type bioreactor bioreactor or rotary bioreactor. 3.如权利要求1所述的一种可工程化放大的间接接触共培养体系,其特征在于,所述的分布在生物反应器中的微小单元颗粒总体积占据生物反应器容积的10-90%。3. A kind of indirect contact co-cultivation system that can be enlarged by engineering as claimed in claim 1, is characterized in that, the total volume of the tiny unit particles distributed in the bioreactor occupies 10-90% of the volume of the bioreactor. %. 4.如权利要求1所述的一种可工程化放大的间接接触共培养体系,其特征在于,所述的球形水凝胶载体的成分包括海藻酸盐及壳聚糖;同时还含有胶原、基质胶、硫酸软骨素、纤连蛋白中的一种或一种以上。4. A kind of indirect contact co-culture system that can be enlarged by engineering as claimed in claim 1, is characterized in that, the composition of described spherical hydrogel carrier comprises alginate and chitosan; Also contains collagen, One or more of matrigel, chondroitin sulfate, and fibronectin. 5.如权利要求4所述的一种可工程化放大的间接接触共培养体系,其特征在于,所述的球形水凝胶载体的壳部分是壳聚糖与海藻酸盐混合物之间通过静电交联形成的聚电解质络合水凝胶膜,膜厚在30微米以下,膜孔隙在5微米以下。5. A kind of indirect contact co-cultivation system that can be engineered enlarged as claimed in claim 4, is characterized in that, the shell part of described spherical hydrogel carrier is formed by static electricity between chitosan and alginate mixture. The polyelectrolyte complex hydrogel membrane formed by cross-linking has a film thickness of less than 30 microns and a membrane pore of less than 5 microns. 6.如权利要求4所述的一种可工程化放大的间接接触共培养体系,其特征在于,在所述球形水凝胶载体中,海藻酸盐包括海藻酸钙盐或海藻酸钡盐中的一种或二种。6. A kind of indirect contact co-cultivation system that can be engineered and enlarged as claimed in claim 4 is characterized in that, in the spherical hydrogel carrier, the alginate comprises calcium alginate or barium alginate one or two of. 7.如权利要求1所述的一种可工程化放大的间接接触共培养体系,其特征在于,所述的微小单元颗粒的制备方法包括如下步骤:7. A kind of engineerable amplified indirect contact co-cultivation system as claimed in claim 1, characterized in that, the preparation method of said tiny unit particles comprises the following steps: A、配制浓度10-50g/L的海藻酸盐溶液,所述的海藻酸盐为海藻酸钠或海藻酸钾中的一种或两种;A, prepare the alginate solution of concentration 10-50g/L, described alginate is one or both in sodium alginate or potassium alginate; B、配制浓度2-50g/L的胶原溶液、壳聚糖溶液、基质胶溶液、硫酸软骨素溶液或纤连蛋白溶液;B. Collagen solution, chitosan solution, matrigel solution, chondroitin sulfate solution or fibronectin solution with a concentration of 2-50g/L are prepared; C、配制凝胶浴水溶液:凝胶浴中含有总浓度5-30g/L氯化钙或氯化钡的一种或两种;还含有总浓度1-20g/L氯化钠或氯化钾中的一种或二种;还含有总浓度0.5-20g/L柠檬酸钠或磷酸钠或磷酸氢二钠或磷酸二氢钠中的一种或二种以上;还含有总浓度0-30g/L吐温或F68中的一种或二种;C. Preparation of gel bath aqueous solution: the gel bath contains one or two kinds of calcium chloride or barium chloride with a total concentration of 5-30g/L; it also contains sodium chloride or potassium chloride with a total concentration of 1-20g/L One or two of them; it also contains one or more of the total concentration of 0.5-20g/L sodium citrate or sodium phosphate or disodium hydrogen phosphate or sodium dihydrogen phosphate; it also contains a total concentration of 0-30g/L One or two of L Tween or F68; D、配制浓度1-10g/L壳聚糖溶液;D, preparation concentration 1-10g/L chitosan solution; E、将步骤A配制的海藻酸盐溶液与步骤B配制的胶原溶液、壳聚糖溶液、基质胶溶液、硫酸软骨素溶液或纤连蛋白溶液中的一种或一种以上均匀混合,混合液中海藻酸盐浓度保持在10g/L以上;E, uniformly mix the alginate solution prepared in step A with one or more of the collagen solution prepared in step B, chitosan solution, matrigel solution, chondroitin sulfate solution or fibronectin solution, the mixed solution The concentration of alginate in the medium is kept above 10g/L; F、将收集的细胞a均匀分散到步骤E制备的混合液中,将含有细胞a的混合溶液通过流体颗粒化技术,形成均匀液滴,液滴进入步骤C配制的凝胶浴溶液中,同时结合温度变化,发生凝胶化反应,即得包埋有细胞a的球形水凝胶载体内核部分;F. Evenly disperse the collected cell a into the mixed solution prepared in step E, pass the mixed solution containing cell a through fluid granulation technology to form uniform droplets, and the droplets enter the gel bath solution prepared in step C, and at the same time Combined with the temperature change, a gelation reaction occurs, and the core part of the spherical hydrogel carrier embedded with cell a is obtained; G、将步骤F获得的包埋有细胞a的球形水凝胶载体内核部分与步骤D配制的壳聚糖溶液反应成膜,载体与壳聚糖溶液的体积比为1:2-1:10,让载体在壳聚糖溶液中处于均匀悬浮状态,进行聚电解质络合反应2-60分钟,即在球形水凝胶载体内核表面形成水凝胶膜,生理盐水或PBS溶液清洗后获得壳核结构的细胞a分布在内部的水凝胶载体;G. React the core part of the spherical hydrogel carrier embedded with cell a obtained in step F with the chitosan solution prepared in step D to form a film, and the volume ratio of the carrier to the chitosan solution is 1:2-1:10 , let the carrier be in a uniform suspension state in the chitosan solution, and carry out the polyelectrolyte complexation reaction for 2-60 minutes, that is, a hydrogel film is formed on the surface of the spherical hydrogel carrier inner core, and the shell core is obtained after washing with normal saline or PBS solution Structured cells a distributed inside the hydrogel carrier; H、将细胞b与步骤G制备的包埋有细胞a的水凝胶载体共孵育1-24小时,获得一种细胞在球形水凝胶内部,另一种细胞分布在球形水凝胶膜表面的间接接触共培养微小单元颗粒。H. Co-incubate cell b with the hydrogel carrier embedded with cell a prepared in step G for 1-24 hours to obtain one type of cell inside the spherical hydrogel and another type of cell distributed on the surface of the spherical hydrogel membrane Indirect contact co-cultivation of tiny unit particles. 8.如权利要求7所述一种可工程化放大的间接接触共培养体系,其特征在于,在所述的球形水凝胶载体制备工艺中,流体颗粒化技术为高压静电场技术、气体锐孔喷雾技术、微流控技术或乳化技术,所制备的球形水凝胶载体的粒径单分散。8. A kind of indirect contact co-cultivation system that can be engineered and enlarged as claimed in claim 7 is characterized in that, in the preparation process of the spherical hydrogel carrier, the fluid granulation technology is high-voltage electrostatic field technology, gas sharp Hole spray technology, microfluidic technology or emulsification technology, the particle size of the prepared spherical hydrogel carrier is monodisperse. 9.按照权利要求1所述可工程化放大的间接接触共培养体系,其特征在于,所述的一种可工程化放大的间接接触共培养体系,可用于肝细胞与基质细胞体外间接接触共培养;干细胞与诱导细胞体外间接接触共培养;干细胞与滋养层细胞体外间接接触共培养;肿瘤细胞与基质细胞体外间接接触共培养,且共培养结束后,胰酶即可将分布在微小单元颗粒表面的细胞消化下来,实现共培养细胞的分离。9. According to claim 1, the indirect contact co-culture system that can be engineered and enlarged is characterized in that, the described amplified engineered indirect contact co-culture system can be used for indirect contact co-culture of hepatocytes and stromal cells in vitro. Culture; in vitro indirect contact co-culture of stem cells and induced cells; in vitro indirect contact co-culture of stem cells and trophoblast cells; in vitro indirect contact co-culture of tumor cells and stromal cells, and after co-cultivation, trypsin can be distributed in micro-unit particles The cells on the surface are digested to achieve the separation of co-cultured cells.
CN201810014471.6A 2018-01-08 2018-01-08 A kind of mediate contact co-culture system for being engineered amplification Pending CN108102915A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810014471.6A CN108102915A (en) 2018-01-08 2018-01-08 A kind of mediate contact co-culture system for being engineered amplification

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810014471.6A CN108102915A (en) 2018-01-08 2018-01-08 A kind of mediate contact co-culture system for being engineered amplification

Publications (1)

Publication Number Publication Date
CN108102915A true CN108102915A (en) 2018-06-01

Family

ID=62218395

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810014471.6A Pending CN108102915A (en) 2018-01-08 2018-01-08 A kind of mediate contact co-culture system for being engineered amplification

Country Status (1)

Country Link
CN (1) CN108102915A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109749999A (en) * 2019-01-29 2019-05-14 南通大学 Tumor culture method in vitro and clinical chemotherapeutic drug screening method
CN114214267A (en) * 2021-12-06 2022-03-22 大连大学 Organoid matrigel microspheres and preparation method and application thereof
CN114703172A (en) * 2022-04-12 2022-07-05 重庆理工大学 Controllable degradation embryo microsphere and preparation method thereof

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101285053A (en) * 2008-05-28 2008-10-15 大连理工大学 A method for co-cultivating umbilical cord blood hematopoietic stem cells and mesenchymal stem cells under dynamic suspension conditions
CN101508975A (en) * 2009-03-26 2009-08-19 大连理工大学 Method for supporting, regulating and controlling amplification of hematopoietic stem/progenitor cell in vitro with microencapsulation osteoblast in hypoxia condition
WO2010030199A1 (en) * 2008-09-15 2010-03-18 Neurotrophincell Pty Limited Stem cell culture
CN102475691A (en) * 2010-11-30 2012-05-30 中国科学院大连化学物理研究所 Alginate-chitosan acyl derivative microcapsules and its preparation and application
CN103881908A (en) * 2012-12-20 2014-06-25 中国科学院大连化学物理研究所 Bioreactor system for cell co-cultivation
CN104436306A (en) * 2014-11-11 2015-03-25 四川大学 Cell-gel material composite microsphere as well as preparation method and application thereof
CN105213317A (en) * 2014-07-01 2016-01-06 中国科学院大连化学物理研究所 A hydrogel microsphere embedded with coagulation-related enzymes
CN105288601A (en) * 2014-07-01 2016-02-03 中国人民解放军沈阳军区总医院 Application of hydrogel microspheres embedded with blood coagulation related enzyme
CN106701730A (en) * 2015-07-27 2017-05-24 中国科学院大连化学物理研究所 Alginate hydrogel microsphere carrier containing galactosyl chitosan molecule and application thereof
CN106867959A (en) * 2015-12-10 2017-06-20 中国科学院大连化学物理研究所 A kind of two kinds of methods of iuntercellular distance of regulation and control

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101285053A (en) * 2008-05-28 2008-10-15 大连理工大学 A method for co-cultivating umbilical cord blood hematopoietic stem cells and mesenchymal stem cells under dynamic suspension conditions
WO2010030199A1 (en) * 2008-09-15 2010-03-18 Neurotrophincell Pty Limited Stem cell culture
CN101508975A (en) * 2009-03-26 2009-08-19 大连理工大学 Method for supporting, regulating and controlling amplification of hematopoietic stem/progenitor cell in vitro with microencapsulation osteoblast in hypoxia condition
CN102475691A (en) * 2010-11-30 2012-05-30 中国科学院大连化学物理研究所 Alginate-chitosan acyl derivative microcapsules and its preparation and application
CN103881908A (en) * 2012-12-20 2014-06-25 中国科学院大连化学物理研究所 Bioreactor system for cell co-cultivation
CN105213317A (en) * 2014-07-01 2016-01-06 中国科学院大连化学物理研究所 A hydrogel microsphere embedded with coagulation-related enzymes
CN105288601A (en) * 2014-07-01 2016-02-03 中国人民解放军沈阳军区总医院 Application of hydrogel microspheres embedded with blood coagulation related enzyme
CN104436306A (en) * 2014-11-11 2015-03-25 四川大学 Cell-gel material composite microsphere as well as preparation method and application thereof
CN106701730A (en) * 2015-07-27 2017-05-24 中国科学院大连化学物理研究所 Alginate hydrogel microsphere carrier containing galactosyl chitosan molecule and application thereof
CN106867959A (en) * 2015-12-10 2017-06-20 中国科学院大连化学物理研究所 A kind of two kinds of methods of iuntercellular distance of regulation and control

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ROMAN A. PEREZ, HAE-WON KIM: "Core–shell designed scaffolds for drug delivery and tissue engineering", 《ACTA BIOMATERIALIA》 *
YUKIKO T MATSUNAGA, YUYA MORIMOTO, SHOJI TAKEUCHI: "Molding cell beads for rapid construction of macroscopic 3D tissue architecture", 《ADV. MATER.》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109749999A (en) * 2019-01-29 2019-05-14 南通大学 Tumor culture method in vitro and clinical chemotherapeutic drug screening method
CN114214267A (en) * 2021-12-06 2022-03-22 大连大学 Organoid matrigel microspheres and preparation method and application thereof
CN114214267B (en) * 2021-12-06 2024-04-09 大连大学 Organoid matrigel microsphere and preparation method and application thereof
CN114703172A (en) * 2022-04-12 2022-07-05 重庆理工大学 Controllable degradation embryo microsphere and preparation method thereof

Similar Documents

Publication Publication Date Title
Sefton et al. Making microencapsulation work: conformal coating, immobilization gels and in vivo performance
Liu et al. Biomedical applications of layer‐by‐layer self‐assembly for cell encapsulation: Current status and future perspectives
Bodiou et al. Microcarriers for upscaling cultured meat production
US5015576A (en) Macroporous particles for cell cultivation or chromatography
WO2022237003A1 (en) Multi-stage suspension printing method for constructing complex heterogeneous tissue/organ
Liu et al. Three-dimensional hepatic lobule-like tissue constructs using cell-microcapsule technology
Sakai et al. Enzymatically fabricated and degradable microcapsules for production of multicellular spheroids with well-defined diameters of less than 150 μm
Liu et al. Mild formation of core–shell hydrogel microcapsules for cell encapsulation
CN108102915A (en) A kind of mediate contact co-culture system for being engineered amplification
CN112852706A (en) 3D (three-dimensional) organ engineering method based on aqueous two-phase droplet microfluidics
US11667888B2 (en) Microbeads for cell culture and method of monitoring cell culture using the same
Ladeira et al. Core–shell microcapsules: biofabrication and potential applications in tissue engineering and regenerative medicine
CN109806919A (en) A kind of preparation method of 3D cell culture gelatin methacrylamide core-shell microspheres
Zhou et al. Scalable encapsulation of hepatocytes by electrostatic spraying
Zhang et al. Towards a New 3Rs Era in the construction of 3D cell culture models simulating tumor microenvironment
Uludag et al. Viability and protein secretion from human Hepatoma (HepG2) cells encapsulated in 400‐μm polyacrylate microcapsules by submerged nozzle–liquid jet extrusion
Yu et al. Microfluidic preparation, shrinkage, and surface modification of monodispersed alginate microbeads for 3D cell culture
CN109810935A (en) Preparation method of gelatin methacrylamide core-shell microspheres cultured by cell partition
Pang et al. Organization of liver organoids using Raschig ring-like micro-scaffolds and triple co-culture: Toward modular assembly-based scalable liver tissue engineering
Li et al. Preparation of microcarriers based on zein and their application in cell culture
Sánchez et al. Encapsulation of cells in alginate gels
CN103881908A (en) Bioreactor system for cell co-cultivation
Sakai et al. Wrapping tissues with a pre-established cage-like layer composed of living cells
Yoon et al. Fabrication of type I collagen microcarrier using a microfluidic 3D T-junction device and its application for the quantitative analysis of cell–ECM interactions
Long et al. 3D cell culture based on artificial cells and hydrogel under microgravity for bottom-up microtissue constructs

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180601

RJ01 Rejection of invention patent application after publication